glp 1 and rheumatoid arthritis GLP-1s for diabetes reduce arthritis, gout risk Stories like this are why

As discussed in a comprehensive review article [611], the anatomical location of GLP-1R within the cardiovascular system has species-related differences

Oral GLP-1 formulations coming to market in 2026 may offer even more cost flexibility, although leading products like semaglutide and tirzepatide are unlikely to face generic competition until the next decade

Asia Pacific is emerging as the fastest-growing region, driven by rising rates of type 2 diabetes, urban obesity, and expanding healthcare access

Why Are GLP-1 and Peptide Therapies Becoming Popular

Dejgaard, J

That hasnt escaped the consciousness of pretty much everyone on the planet, and predictably, the past year has seen an explosion of people using these drugs for that purpose